CMS issues 2018 Medicare Advantage, prescription drug plan star ratings
The Centers for Medicare & Medicaid Services this week published its star ratings for 2018 Medicare Advantage and prescription drug plans. Approximately 44% of MA plans that offer prescription drug coverage will have an overall rating of four stars or higher in 2018, and about 52% of stand-alone prescription drug plans will have a rating of four stars or higher in 2018. Open enrollment for 2018 MA and prescription drug plans begins Sunday and ends Dec. 7. CMS recently released premium and cost information for MA and Part D prescription drug plans for the 2018 calendar year.
Related News Articles
Headline
The Senate Special Committee on Aging held a hearing Feb. 11 on issues impacting physician burnout. The AHA provided a statement for the hearing and urged…
Perspective
More than 34.1 million Americans were enrolled in a Medicare Advantage plan in 2025, accounting for 54% of all Medicare beneficiaries. We have seen enrollment…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released proposed changes to Medicare Advantage plan capitation rates and Part D payment policies for…
Headline
The AHA Jan. 26 expressed support and provided its perspective on certain provisions within the Centers for Medicare & Medicaid Services’ proposed…
Headline
The comment period for the Centers for Medicare & Medicaid Services' proposed rule for policies governing the Medicare Advantage and Part D programs for…